Literature DB >> 467605

Immunological profile of breast cancer patients in early or advanced disease.

E Menconi, A Barzi, M Greco, M C Caprino, L De Vecchis, F Muggia.   

Abstract

Immune reactivity of patients with early or advanced breast cancer, compared with healthy controls, has been measured using in vivo and in vitro tests. The results of our study show that impairment of cellular responsiveness occurred in women with advanced disease.

Entities:  

Mesh：

Year:  1979        PMID： 467605     DOI： 10.1007/bf01968273

Source DB:  PubMed          Journal:  Experientia        ISSN： 0014-4754


  3 in total

1.  Cell-mediated immune status of breast cancer patients: evaluation by skin tests, lymphocyte stimulation, and counts of rosette-forming cells.

Authors:  T Nemoto; T Han; J Minowada; V Angkur; A Chamberlain; L Dao
Journal:  J Natl Cancer Inst       Date:  1974-09       Impact factor: 13.506

2.  The use of [125I]deoxyuridine for semi-microevaluation of human lymphocyte response to phytohemagglutinin in vitro.

Authors:  E Menconi; M Neri; V Sorci; L Frati
Journal:  J Immunol Methods       Date:  1978       Impact factor: 2.303

3.  Lymphocyte reactivity in cancer patients: correlation with tumor histology and clinical stage.

Authors:  W J Catalona; W F Sample; P B Chretien
Journal:  Cancer       Date:  1973-01       Impact factor: 6.860
  3 in total
  1 in total

1.  T lymphocyte subsets in the peripheral blood of patients with benign and malignant breast disease.

Authors:  D R McCluskey; A D Roy; W P Abram; W M Martin
Journal:  Br J Cancer       Date:  1983-02       Impact factor: 7.640
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.